Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI

Eur J Radiol. 2016 Jan;85(1):96-102. doi: 10.1016/j.ejrad.2015.10.018. Epub 2015 Nov 2.

Abstract

Purpose: To compare the morphology and minimum apparent diffusion coefficient (ADC) values among breast cancer subtypes.

Methods: Ninety-three patients, who underwent breast MRI and collectively had 98 pathologically proven invasive carcinomas, were enrolled. Morphology was evaluated according to BIRADS-MRI. Minimum ADC was measured. Morphology and minimum ADC were compared among subtypes. Multivariate logistic regression analyses were used to identify the characteristics associated with different subtypes.

Results: Oval/round shape was significantly associated with triple-negative (TN) cancer (TN vs. non-TN: 90.9% vs. 45.2%; p=0.0123). Rim enhancement was significantly less frequent in Luminal A (Luminal A vs. non-Luminal A: 34.2% vs. 76.1%; p=0.0003). The minimum ADC of Luminal A was significantly higher than that of Luminal B (HER2-negative) (834 vs. 748×10(-6)mm(2)/s; p<0.025). The minimum ADC of the TN-special type was significantly higher than that of TN-ductal (997 vs. 702×10(-6)mm(2)/s; p<0.025). On the multivariate analysis comparing the characteristics associated with Luminal A vs. Luminal B (HER2-negative), the internal enhancement characteristics of the mass and minimum ADC were significant factors.

Conclusion: Morphology and minimum ADC would be useful in distinguishing breast cancer subtypes.

Keywords: Breast cancer subtypes; Diffusion weighed imaging; Ki-67; Magnetic resonance imaging.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood
  • Breast / pathology*
  • Breast Neoplasms / blood
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / blood
  • Carcinoma, Ductal, Breast / pathology*
  • Diffusion Magnetic Resonance Imaging*
  • Female
  • Humans
  • Ki-67 Antigen / blood*
  • Magnetic Resonance Imaging
  • Middle Aged
  • Reproducibility of Results
  • Retrospective Studies

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen